These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3521482)

  • 1. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
    Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cephamycins by various beta-lactamases from gram-negative bacteria.
    Minami S; Matsubara N; Yotsuji A; Araki H; Watanabe Y; Yasuda T; Saikawa I; Mitsuhashi S
    J Antibiot (Tokyo); 1984 May; 37(5):577-87. PubMed ID: 6610674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta-lactamase from Proteus vulgaris that hydrolyses newly introduced cephalosporins.
    Pagani L; Perduca M; Romero E
    Microbiologica; 1983 Apr; 6(2):163-8. PubMed ID: 6306402
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of cephalosporinase from Proteus morganii.
    Toda M; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
    Ikeda Y; Fukuoka Y; Motomura K; Yasuda T; Nishino T
    Antimicrob Agents Chemother; 1990 Jan; 34(1):94-7. PubMed ID: 2183712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic studies of cephalothin, cefazolin and cefmetazole in the neonates and the premature babies.
    Sakata Y
    Kurume Med J; 1980; 27(4):275-98. PubMed ID: 6946258
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephamycin derivatives: comparison of the in vitro and in vivo antibacterial activities of SQ 14,359, CS-1170, and cefoxitin.
    Gadebusch HH; Schwind R; Lukaszow P; Whitney R; McRipley RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):1046-58. PubMed ID: 711611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity and beta-lactamase stability of cefazaflur compared with those of beta-lactamase-stable cephalosporins.
    Aswapokee N; Neu HC
    Antimicrob Agents Chemother; 1979 Mar; 15(3):444-6. PubMed ID: 313753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infections for the evaluation of beta-lactamase resistance.
    Xerri L; Orsolini P; Erani E; Broggio R
    Antimicrob Agents Chemother; 1982 Feb; 21(2):201-3. PubMed ID: 6978673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.